CNTN

Insider Trades

Name	Value	Action	Price	Current Price
Stetz Gary S.Director $43k12.5k shares SellMay 26, 2026 $3.47 --
Stetz Gary S.Director $51k15k shares SellMay 22, 2026 $3.41 --
Stetz Gary S.Director $51k15k shares SellMay 22, 2026 $3.40 --
Stetz Gary S.Director $44k12.9k shares SellMay 22, 2026 $3.44 --
Stetz Gary S.Director $35k10k shares SellMay 22, 2026 $3.45 --
Stetz Gary S.Director $34k10k shares SellMay 22, 2026 $3.40 --

News

prnewswire.comCanton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®prnewswire.comJun 18

prnewswire.comCanton Strategic Holdings, Inc. Announces Authorization of Share Repurchase Programprnewswire.comJun 16

prnewswire.comCanton Strategic Holdings Reports First Quarter 2026 Financial and Operational Resultsprnewswire.comMay 13

prnewswire.comCanton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Updateprnewswire.comApr 20

prnewswire.comCanton Strategic Holdings Reports Full Year 2025 Financial and Operational Resultsprnewswire.comMar 31

Trade CNTN

About Canton Strategic Holdings Inc

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas. The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development. Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial. Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

CEO: Mark Wendland
IPO Date: Mar 28, 2024

Market Data

Open: $3.50
High: $3.51
Low: $3.18
Volume: 2.8M
Avg Volume: 730.6K
52W High: $9.08
52W Low: $1.08

Valuation

Market Cap: $117M
Enterprise Value: $76M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-16M
Revenue: $0
Net Income: $-36M
Cash: $17M
Debt: $0

Events

EarningsMay 13

actual -0.17